Name

Apolizumab

Alternate Names

Hu1D10
Humanized 1D10
Remitogen
SMART1D1D

Abbreviations

None

Category

Biologic therapy (BRM, immunotherapy)

Subcategory

Monoclonal antibody

NSC Number

704867

Primary Site

Leukemia
lymphoma
other cancer

Histology

None

Remarks

Phase I ALL, other, Phase II NHL B-cell Disappointing Phase II results. Antibody. Protein Design Labs, NCI.

Coding

This drug should be coded
Glossary